These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37729381)

  • 1. Severe acute respiratory syndrome coronavirus 2 seroprevalence among patients with pulmonary tuberculosis.
    Dias NJD; Silva MSD; Barbosa MS; Pereira GR; Silva DR
    Rev Assoc Med Bras (1992); 2023; 69(9):e20230661. PubMed ID: 37729381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-Vaccination Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Workers at Three Japanese Hospitals.
    Takayama Y; Komatsu T; Wada T; Nihonyanagi S; Hoshiyama T; Moriya T; Shimamura S; Kajigaya N; Naito M; Takeuchi O; Bando Y; Watanabe M; Iwamura M; Hanaki H
    J Nippon Med Sch; 2022 Nov; 89(5):513-519. PubMed ID: 35644553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program.
    Stone M; Di Germanio C; Wright DJ; Sulaeman H; Dave H; Fink RV; Notari EP; Green V; Strauss D; Kessler D; Destree M; Saa P; Williamson PC; Simmons G; Stramer SL; Opsomer J; Jones JM; Kleinman S; Busch MP;
    Clin Infect Dis; 2022 Mar; 74(5):871-881. PubMed ID: 34111244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in SARS-CoV-2 seroprevalence in children in the region of Asturias, Northern Spain.
    García-García E; Rodríguez-Pérez M; Pérez-Solís D; Pérez-Méndez C; Molinos-Norniella C; Cobo-Ruisánchez Á; Fernández Fernández EM; González NG; Calle-Miguel L
    World J Pediatr; 2022 Dec; 18(12):835-844. PubMed ID: 36169886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe acute respiratory syndrome coronavirus 2 antibody prevalence in adult patients with short bowel syndrome-A German multicenter cross-sectional study.
    Blüthner E; Pape UF; Blumenstein I; Wichmann J; Tacke F; Moosburner S
    JPEN J Parenter Enteral Nutr; 2022 Aug; 46(6):1404-1411. PubMed ID: 35616296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population-Weighted Seroprevalence From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Vaccination, and Hybrid Immunity Among US Blood Donations From January to December 2021.
    Busch MP; Stramer SL; Stone M; Yu EA; Grebe E; Notari E; Saa P; Ferg R; Manrique IM; Weil N; Fink RV; Levy ME; Green V; Cyrus S; Williamson PC; Haynes J; Groves J; Krysztof D; Custer B; Kleinman S; Biggerstaff BJ; Opsomer JD; Jones JM
    Clin Infect Dis; 2022 Oct; 75(Suppl 2):S254-S263. PubMed ID: 35684973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Seroprevalence of SARS-CoV-2 and Risk Factors Associated With COVID-19 Infection Among Outpatients in Virginia.
    Rogawski McQuade ET; Guertin KA; Becker L; Operario D; Gratz J; Guan D; Khan F; White J; McMurry TL; Shah B; Garofalo S; Southerland M; Bear K; Brush J; Allen C; Frayser A; Vokes R; Pershad R; Peake L; deFilippi C; Barackman K; Bearman G; Bidanset A; Farrell F; Trump D; Houpt ER
    JAMA Netw Open; 2021 Feb; 4(2):e2035234. PubMed ID: 33555331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Prevalence of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (Anti-SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey.
    Nkuba AN; Makiala SM; Guichet E; Tshiminyi PM; Bazitama YM; Yambayamba MK; Kazenza BM; Kabeya TM; Matungulu EB; Baketana LK; Mitongo NM; Thaurignac G; Leendertz FH; Vanlerberghe V; Pelloquin R; Etard JF; Maman D; Mbala PK; Ayouba A; Peeters M; Muyembe JT; Delaporte E; Ahuka SM
    Clin Infect Dis; 2022 Mar; 74(5):882-890. PubMed ID: 34089598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-Year Seroprevalence Surveys of SARS-CoV-2 Antibodies among Outpatients and Healthcare Workers in Ehime, Japan.
    Suemori K; Taniguchi Y; Okamoto A; Murakami A; Ochi F; Aono H; Hato N; Osawa H; Miyamoto H; Sugiyama T; Yamashita M; Tauchi H; Takenaka K
    Jpn J Infect Dis; 2022 Sep; 75(5):523-526. PubMed ID: 35650038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Cross-Sectional Study Examining the Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies in a University Student Population.
    Tilley K; Ayvazyan V; Martinez L; Nanda N; Kawaguchi ES; O'Gorman M; Conti D; Gauderman WJ; Van Orman S
    J Adolesc Health; 2020 Dec; 67(6):763-768. PubMed ID: 33071164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
    Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
    Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-Based Serosurvey for Severe Acute Respiratory Syndrome Coronavirus 2 Transmission, Chennai, India.
    Selvaraju S; Kumar MS; Thangaraj JWV; Bhatnagar T; Saravanakumar V; Kumar CPG; Sekar K; Ilayaperumal E; Sabarinathan R; Jagadeesan M; Hemalatha MS; Murhekar MV;
    Emerg Infect Dis; 2021 Feb; 27(2):586-589. PubMed ID: 33496222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of SARS-CoV-2 among high-risk healthcare workers in a MERS-CoV endemic area.
    Alroqi F; Masuadi E; Alabdan L; Nogoud M; Aljedaie M; Abu-Jaffal AS; Barhoumi T; Almasoud A; Alharbi NK; Alsaedi A; Khan M; Arabi YM; Nasr A
    J Infect Public Health; 2021 Sep; 14(9):1268-1273. PubMed ID: 34479078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020.
    Shakiba M; Nazemipour M; Salari A; Mehrabian F; Nazari SSH; Rezvani SM; Ghasempour Z; Heidarzadeh A; Mansournia MA
    Emerg Infect Dis; 2021 Feb; 27(2):636-638. PubMed ID: 33349310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection among Veterans Affairs healthcare system employees suggests higher risk of infection when exposed to SARS-CoV-2 outside the work environment.
    Dimcheff DE; Schildhouse RJ; Hausman MS; Vincent BM; Markovitz E; Chensue SW; Deng J; McLeod M; Hagan D; Russell J; Bradley SF
    Infect Control Hosp Epidemiol; 2021 Apr; 42(4):392-398. PubMed ID: 32962771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of SARS-CoV-2 antibodies in the poorest region of Brazil: results from a population-based study.
    de Souza Araújo AA; Quintans-Júnior LJ; Heimfarth L; Schimieguel DM; Corrêa CB; de Moura TR; Cavalcante RCM; Rodrigues Bomfim R; Grespan R; Santana Rodrigues L; Dos Santos DM; de Sá Resende A; de Lima Silva N; da Silva Santos ACR; Dantas Araújo JM; de Souza MF; de Oliveira Góes MA; Santana Santos V; Martins-Filho PR
    Epidemiol Infect; 2021 May; 149():e130. PubMed ID: 34001292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-occupational and occupational factors associated with specific SARS-CoV-2 antibodies among hospital workers - A multicentre cross-sectional study.
    Kahlert CR; Persi R; Güsewell S; Egger T; Leal-Neto OB; Sumer J; Flury D; Brucher A; Lemmenmeier E; Möller JC; Rieder P; Stocker R; Vuichard-Gysin D; Wiggli B; Albrich WC; Babouee Flury B; Besold U; Fehr J; Kuster SP; McGeer A; Risch L; Schlegel M; Friedl A; Vernazza P; Kohler P
    Clin Microbiol Infect; 2021 Sep; 27(9):1336-1344. PubMed ID: 34020033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.
    Galanis P; Vraka I; Fragkou D; Bilali A; Kaitelidou D
    J Hosp Infect; 2021 Feb; 108():120-134. PubMed ID: 33212126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
    Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
    PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive infection control measures prevent hospital-acquired severe acute respiratory syndrome coronavirus 2 infection: A single-center prospective cohort study and seroprevalence survey.
    Hori H; Fukuchi T; Sanui M; Moriya T; Sugawara H
    PLoS One; 2021; 16(10):e0257513. PubMed ID: 34634076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.